Jeff Garro
Stock Analyst at Stephens & Co.
(0.72)
# 3,888
Out of 4,944 analysts
50
Total ratings
26.47%
Success rate
-12.37%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $14.46 | +38.31% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $20.12 | +39.17% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $277.80 | +0.79% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $3.20 | +56.49% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $11.22 | +51.52% | 5 | Feb 27, 2025 | |
| EVH Evolent Health | Maintains: Equal-Weight | $16 → $12 | $9.38 | +28.00% | 5 | Jan 21, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $26 | $21.13 | +23.05% | 3 | Jan 7, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $3.96 | +26.26% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $63.45 | -13.31% | 1 | Dec 20, 2024 | |
| OPRX OptimizeRx | Initiates: Equal-Weight | $5.5 | $17.41 | -68.41% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $189.79 | +31.72% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $17.55 | -3.13% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $28.37 | -1.30% | 8 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $7.39 | +279.15% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $15.06 | +32.80% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $3.62 | +7.88% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $2.05 | +46.34% | 3 | May 6, 2022 |
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $14.46
Upside: +38.31%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $20.12
Upside: +39.17%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $277.80
Upside: +0.79%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.20
Upside: +56.49%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $11.22
Upside: +51.52%
Evolent Health
Jan 21, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $9.38
Upside: +28.00%
Privia Health Group
Jan 7, 2025
Reiterates: Overweight
Price Target: $26
Current: $21.13
Upside: +23.05%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $3.96
Upside: +26.26%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $63.45
Upside: -13.31%
OptimizeRx
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $17.41
Upside: -68.41%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $189.79
Upside: +31.72%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $17.55
Upside: -3.13%
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $28.37
Upside: -1.30%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $7.39
Upside: +279.15%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $15.06
Upside: +32.80%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $3.62
Upside: +7.88%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $2.05
Upside: +46.34%